Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Orexin 1 receptor might be a therapeutic target in PTSD-related psychosis

Feb. 23, 2021

NGF-loaded biodegradable microcapsules show morphogenic effects on hippocampal neuron cultures

Feb. 23, 2021

Cassava Sciences outlines pivotal phase III program for simufilam in Alzheimer's disease

Feb. 23, 2021

EMT drives zebrafish spinal cord repair

Feb. 23, 2021

Enzyme controlling neural stem cell proliferation identified

Feb. 23, 2021

Perception Neuroscience reports first phase I data on PCN-101

Feb. 23, 2021

Bionomics reports PK data on new solid dose oral tablet formulation of BNC-210

Feb. 22, 2021

AUT-00206 ameliorates audition symptoms tied to schizophrenia

Feb. 22, 2021

Study links antidepressant action to TRKB binding

Feb. 22, 2021

Dosing begins in phase II trial of BBP-418 for limb girdle muscular dystrophy type 2i

Feb. 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 20, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...